Senior Manager, Clinical Business Systems

Job description

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Manager, Clinical Systems is a hands-on technical leader responsible for the daily administration, support, and ongoing enhancement of core clinical systems, including eTMF and CTMS, as well as the implementation and optimization of future platforms that support clinical operations (e.g., RBQM, Study Start-Up, IRT/RTSM). This role will actively perform and oversee system configuration, user management, period...